Matches in Wikidata for { <http://www.wikidata.org/entity/Q66411203> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q66411203 description "clinical trial" @default.
- Q66411203 description "ensayu clínicu" @default.
- Q66411203 description "klinisch onderzoek" @default.
- Q66411203 description "клінічне випробування" @default.
- Q66411203 description "կլինիկական փորձարկում" @default.
- Q66411203 name "A Drug-drug Interaction (DDI) Study to Assess the Effect of INC280 on the Pharmacokinetics of Digoxin and Rosuvastatin in Patients With cMET-dysregulated Advanced Solid Tumors" @default.
- Q66411203 name "A Drug-drug Interaction" @default.
- Q66411203 type Item @default.
- Q66411203 label "A Drug-drug Interaction (DDI) Study to Assess the Effect of INC280 on the Pharmacokinetics of Digoxin and Rosuvastatin in Patients With cMET-dysregulated Advanced Solid Tumors" @default.
- Q66411203 label "A Drug-drug Interaction" @default.
- Q66411203 prefLabel "A Drug-drug Interaction (DDI) Study to Assess the Effect of INC280 on the Pharmacokinetics of Digoxin and Rosuvastatin in Patients With cMET-dysregulated Advanced Solid Tumors" @default.
- Q66411203 prefLabel "A Drug-drug Interaction" @default.
- Q66411203 P1132 Q66411203-97EB0D2B-3BF1-42BE-A646-ABE88601F1D8 @default.
- Q66411203 P1476 Q66411203-2DA57EC7-B80C-4A24-8EC1-C48EAA229104 @default.
- Q66411203 P17 Q66411203-33CC44A3-498A-4E4F-9F52-3F56F650BC5C @default.
- Q66411203 P17 Q66411203-502F100E-54E9-4E06-B56F-2A44C5FB0E1C @default.
- Q66411203 P17 Q66411203-65429203-548E-4F02-BD1A-FA893E9459C8 @default.
- Q66411203 P17 Q66411203-7D380C4C-57F9-444E-9E02-A42DEB989D70 @default.
- Q66411203 P17 Q66411203-9B6B3B01-B2AF-4A62-A7C5-9982D9220DD1 @default.
- Q66411203 P17 Q66411203-CB8F5465-2C8D-42D5-A549-63F923B7008E @default.
- Q66411203 P17 Q66411203-FC8B37DE-26DB-4BF7-8FE6-25F06B444B24 @default.
- Q66411203 P2899 Q66411203-D451F66C-75E2-46C7-9304-6C72A6371AD3 @default.
- Q66411203 P3098 Q66411203-A717E63A-D1FE-400D-9FD8-8E335394828E @default.
- Q66411203 P31 Q66411203-6D38E636-92EA-483B-B22A-3AE22622ACF3 @default.
- Q66411203 P4844 Q66411203-77744779-A6DE-401D-9A24-953BFF323671 @default.
- Q66411203 P580 Q66411203-50E777DA-9A86-4DD8-A567-73136B43465E @default.
- Q66411203 P582 Q66411203-03B62108-EF73-48AF-B513-F6EF0654A9A7 @default.
- Q66411203 P6099 Q66411203-823EE6FF-A58F-4B9A-B71E-BBB0C48A471E @default.
- Q66411203 P8363 Q66411203-1A0B4BDA-0984-4E3F-80A1-D1DB0934DFF7 @default.
- Q66411203 P859 Q66411203-8FE5D90D-0F87-4E84-AAE0-E403EB0932BA @default.
- Q66411203 P1132 "+32" @default.
- Q66411203 P1476 "A Phase I, Multicenter, Open-label, Single-sequence Drug-drug Interaction Study to Assess the Effect of INC280 on the Pharmacokinetics of Digoxin and Rosuvastatin in Patients With cMET-dysregulated Advanced Solid Tumors" @default.
- Q66411203 P17 Q145 @default.
- Q66411203 P17 Q29 @default.
- Q66411203 P17 Q30 @default.
- Q66411203 P17 Q31 @default.
- Q66411203 P17 Q38 @default.
- Q66411203 P17 Q40 @default.
- Q66411203 P17 Q41 @default.
- Q66411203 P2899 "+18" @default.
- Q66411203 P3098 "NCT02626234" @default.
- Q66411203 P31 Q30612 @default.
- Q66411203 P4844 Q422222 @default.
- Q66411203 P580 "2015-12-08T00:00:00Z" @default.
- Q66411203 P582 "2017-02-28T00:00:00Z" @default.
- Q66411203 P6099 Q5452194 @default.
- Q66411203 P8363 Q78089383 @default.
- Q66411203 P859 Q507154 @default.